PacificHealth Laboratories, Inc.
PHLI
OTC PK
| 09/30/2012 | 06/30/2012 | 03/31/2012 | 12/31/2011 | 09/30/2011 | |
|---|---|---|---|---|---|
| Revenue | 6.67M | 6.92M | 6.93M | 6.91M | 6.95M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 6.67M | 6.92M | 6.93M | 6.91M | 6.95M |
| Cost of Revenue | 4.10M | 4.09M | 3.97M | 3.93M | 4.00M |
| Gross Profit | 2.57M | 2.83M | 2.96M | 2.99M | 2.95M |
| SG&A Expenses | 3.44M | 3.47M | 3.45M | 3.40M | 3.34M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 7.59M | 7.62M | 7.47M | 7.37M | 7.38M |
| Operating Income | -927.20K | -698.70K | -538.50K | -459.20K | -437.30K |
| Income Before Tax | -943.50K | -714.80K | -553.30K | -486.30K | -539.20K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -0.94 | -0.71 | -0.55 | -0.49 | -0.54 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -943.50K | -714.80K | -553.30K | -486.30K | -539.20K |
| EBIT | -927.20K | -698.70K | -538.50K | -459.20K | -437.30K |
| EBITDA | -861.60K | -647.70K | -500.00K | -417.60K | -389.10K |
| EPS Basic | -0.05 | -0.03 | -0.03 | -0.02 | -0.03 |
| Normalized Basic EPS | -0.03 | -0.02 | -0.02 | -0.01 | -0.02 |
| EPS Diluted | -0.05 | -0.04 | -0.03 | -0.03 | -0.04 |
| Normalized Diluted EPS | -0.03 | -0.02 | -0.02 | -0.01 | -0.02 |
| Average Basic Shares Outstanding | 83.48M | 83.47M | 82.33M | 78.12M | 73.74M |
| Average Diluted Shares Outstanding | 83.48M | 83.47M | 82.53M | 78.49M | 74.11M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
